Aperio Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.17M | Buy |
15,210
+1,888
| +14% | +$145K | ﹤0.01% | 1511 |
|
|
2020
Q3 | $996K | Buy |
13,322
+2,363
| +22% | +$177K | ﹤0.01% | 1443 |
|
|
2020
Q2 | $690K | Buy |
10,959
+329
| +3% | +$20.7K | ﹤0.01% | 1600 |
|
|
2020
Q1 | $446K | Buy |
10,630
+2,713
| +34% | +$114K | ﹤0.01% | 1714 |
|
|
2019
Q4 | $360K | Sell |
7,917
-2,653
| -25% | -$121K | ﹤0.01% | 1983 |
|
|
2019
Q3 | $484K | Sell |
10,570
-1,437
| -12% | -$65.8K | ﹤0.01% | 1773 |
|
|
2019
Q2 | $704K | Buy |
12,007
+4,426
| +58% | +$260K | ﹤0.01% | 1594 |
|
|
2019
Q1 | $340K | Buy |
7,581
+710
| +10% | +$31.8K | ﹤0.01% | 1950 |
|
|
2018
Q4 | $268K | Buy |
+6,871
| New | +$268K | ﹤0.01% | 1994 |
|
|
2017
Q2 | – | Sell |
-1,740
| Closed | -$25K | – | 2229 |
|
|
2017
Q1 | $25K | Sell |
1,740
-243
| -12% | -$3.49K | ﹤0.01% | 2137 |
|
|
2016
Q4 | $28K | Sell |
1,983
-3,937
| -67% | -$55.6K | ﹤0.01% | 2113 |
|
|
2016
Q3 | $104K | Sell |
5,920
-1,854
| -24% | -$32.6K | ﹤0.01% | 2022 |
|
|
2016
Q2 | $133K | Sell |
7,774
-49
| -0.6% | -$838 | ﹤0.01% | 1942 |
|
|
2016
Q1 | $154K | Buy |
7,823
+1,695
| +28% | +$33.4K | ﹤0.01% | 1921 |
|
|
2015
Q4 | $116K | Buy |
6,128
+351
| +6% | +$6.64K | ﹤0.01% | 1911 |
|
|
2015
Q3 | $110K | Buy |
5,777
+779
| +16% | +$14.8K | ﹤0.01% | 1854 |
|
|
2015
Q2 | $232K | Buy |
4,998
+23
| +0.5% | +$1.07K | ﹤0.01% | 1780 |
|
|
2015
Q1 | $217K | Buy |
4,975
+42
| +0.9% | +$1.83K | ﹤0.01% | 1781 |
|
|
2014
Q4 | $171K | Buy |
4,933
+35
| +0.7% | +$1.21K | ﹤0.01% | 1778 |
|
|
2014
Q3 | $205K | Buy |
4,898
+31
| +0.6% | +$1.3K | ﹤0.01% | 1590 |
|
|
2014
Q2 | $285K | Sell |
4,867
-190
| -4% | -$11.1K | ﹤0.01% | 1423 |
|
|
2014
Q1 | $319K | Buy |
+5,057
| New | +$319K | ﹤0.01% | 1581 |
|
|
2013
Q4 | – | Sell |
-4,934
| Closed | -$260K | – | 1589 |
|
|
2013
Q3 | $260K | Sell |
4,934
-197
| -4% | -$10.4K | 0.01% | 1504 |
|
|
2013
Q2 | $395K | Buy |
+5,131
| New | +$395K | 0.01% | 1135 |
|